ERYTHROMYCIN

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
ERYTHROMYCIN
Generic name
ERYTHROMYCIN
Manufacturer
Direct Rx
Product type
HUMAN PRESCRIPTION DRUG
SPL set ID
9ac4dcd2-8cac-404d-b651-da74062d30ed
SPL ID
4d3a76a9-7324-9988-e063-6394a90a2801
Version
4
Effective date
2026-03-17
Source export date
2026-10-12
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/b25dad4aaef9c88f0e827394a34fbbd1ce7d71422fa46b5d1e123befad498c1d/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:45:51
Harmonized routes table
Harmonized routes
OPHTHALMIC

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The most frequently reported adverse reactions are minor ocular irritations, redness and hypersensitivity reactions.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.